El papel de la senescencia, su relevancia terapéutica e implicaciones clínicas en el microambiente tumoral
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Ver abstracta en PubMed
Resumen
Este resumen es generado por máquina.La senescencia celular, un estado de arresto del ciclo celular irreversible, juega un papel complejo en el cáncer. Las células senescentes y sus factores secretados pueden promover o inhibir el crecimiento del tumor, ofreciendo nuevos objetivos terapéuticos.
Área De La Ciencia
- En el campo de la oncología
- Inmunología
- Biología celular
Sus Antecedentes
- La senescencia celular es una detención estable del ciclo celular.
- Se caracteriza por marcadores específicos y el fenotipo secretor asociado a la senescencia (SASP).
- El papel de la senescencia en el microambiente tumoral es complejo y dependiente del contexto.
Objetivo Del Estudio
- Revisar el papel multifacético de la senescencia celular en el microambiente tumoral.
- Para explorar cómo las células senescentes, incluidas las células inmunes y estomales, influyen en la progresión del tumor.
- Para discutir las estrategias terapéuticas actuales y emergentes dirigidas a la senescencia celular en el cáncer.
Principales Métodos
- Revisión de la literatura centrada en la senescencia celular y el cáncer.
- Análisis de la doble función del SASP en la inmunidad tumoral.
- Examen de la participación de las células senescentes en la inmunosupresión y la angiogénesis.
Principales Resultados
- Las células inmunitarias senescentes pueden deteriorar las funciones antitumorales y promover el crecimiento tumoral.
- Las células T senescentes disfuncionales contribuyen a la inmunosupresión y a la resistencia a la inmunoterapia.
- SASP exhibe efectos dependientes del contexto, ayudando a la vigilancia temprana del tumor pero obstaculizando la inmunidad en etapas avanzadas.
Conclusiones
- La senescencia celular presenta una espada de doble filo en el cáncer, influyendo en la progresión del tumor y la respuesta inmune.
- Dirigirse a la senescencia, SASP, o células senescentes ofrece vías prometedoras para nuevas terapias contra el cáncer.
- Las estrategias incluyen inducir, inhibir SASP, eliminar o revertir la senescencia, con potencial para futuras aplicaciones clínicas.
Contact us Si estos videos no son relevantes.
Contact us Si estos videos no son relevantes.
Videos de Conceptos Relacionados
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...